Literature DB >> 27701103

Induced pluripotent stem cells, past and future.

Eirini P Papapetrou1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27701103      PMCID： PMC5234330          DOI： 10.1126/science.aai7626

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  11 in total

1.  From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial.

Authors:  John McNeish; Jason P Gardner; Brian J Wainger; Clifford J Woolf; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2015-07-02       Impact factor: 24.633

Review 2.  Induced Pluripotent Stem Cells Meet Genome Editing.

Authors:  Dirk Hockemeyer; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2016-05-05       Impact factor: 24.633

Review 3.  Molecular Obstacles to Clinical Translation of iPSCs.

Authors:  Natalia Tapia; Hans R Schöler
Journal:  Cell Stem Cell       Date:  2016-07-21       Impact factor: 24.633

4.  Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.

Authors:  Paul W Burridge; Yong Fuga Li; Elena Matsa; Haodi Wu; Sang-Ging Ong; Arun Sharma; Alexandra Holmström; Alex C Chang; Michael J Coronado; Antje D Ebert; Joshua W Knowles; Melinda L Telli; Ronald M Witteles; Helen M Blau; Daniel Bernstein; Russ B Altman; Joseph C Wu
Journal:  Nat Med       Date:  2016-04-18       Impact factor: 53.440

Review 5.  Pluripotent stem cell-based disease modeling: current hurdles and future promise.

Authors:  Nadja Zeltner; Lorenz Studer
Journal:  Curr Opin Cell Biol       Date:  2015-11-27       Impact factor: 8.382

6.  Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells.

Authors:  Eirini P Papapetrou; Gabsang Lee; Nirav Malani; Manu Setty; Isabelle Riviere; Laxmi M S Tirunagari; Kyuichi Kadota; Shoshannah L Roth; Patricia Giardina; Agnes Viale; Christina Leslie; Frederic D Bushman; Lorenz Studer; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2010-12-12       Impact factor: 54.908

7.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 8.  Organogenesis in a dish: modeling development and disease using organoid technologies.

Authors:  Madeline A Lancaster; Juergen A Knoblich
Journal:  Science       Date:  2014-07-17       Impact factor: 47.728

9.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

Review 10.  A decade of transcription factor-mediated reprogramming to pluripotency.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-17       Impact factor: 94.444
View more
  15 in total

Review 1.  Engineered circulatory scaffolds for building cardiac tissue.

Authors:  Shixing Huang; Yang Yang; Qi Yang; Qiang Zhao; Xiaofeng Ye
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Patient-derived induced pluripotent stem cells in cancer research and precision oncology.

Authors:  Eirini P Papapetrou
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

Review 3.  Master regulators in development: Views from the Drosophila retinal determination and mammalian pluripotency gene networks.

Authors:  Trevor L Davis; Ilaria Rebay
Journal:  Dev Biol       Date:  2016-12-13       Impact factor: 3.582

Review 4.  Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders.

Authors:  Yan Chen; Ruiting Wen; Zhigang Yang; Zhanghui Chen
Journal:  Gene Ther       Date:  2021-03-09       Impact factor: 5.250

Review 5.  Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease.

Authors:  Nathaniel K Mullin; Andrew P Voigt; Jessica A Cooke; Laura R Bohrer; Erin R Burnight; Edwin M Stone; Robert F Mullins; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2020-10-29       Impact factor: 21.198

6.  Studying leukemia stem cell properties and vulnerabilities with human iPSCs.

Authors:  Nikolaos Spyrou; Eirini P Papapetrou
Journal:  Stem Cell Res       Date:  2020-12-10       Impact factor: 1.587

7.  Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage.

Authors:  Juan Antonio Fafián-Labora; Jose Antonio Rodríguez-Navarro; Ana O'Loghlen
Journal:  Cell Metab       Date:  2020-06-22       Impact factor: 27.287

8.  Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration.

Authors:  Frank Arnold; Pallavi U Mahaddalkar; Johann M Kraus; Xiaowei Zhong; Wendy Bergmann; Dharini Srinivasan; Johann Gout; Elodie Roger; Alica K Beutel; Eugen Zizer; Umesh Tharehalli; Nora Daiss; Ronan Russell; Lukas Perkhofer; Rupert Oellinger; Qiong Lin; Ninel Azoitei; Frank-Ulrich Weiss; Markus M Lerch; Stefan Liebau; Sarah-Fee Katz; André Lechel; Roland Rad; Thomas Seufferlein; Hans A Kestler; Michael Ott; Amar Deep Sharma; Patrick C Hermann; Alexander Kleger
Journal:  Adv Sci (Weinh)       Date:  2021-05-13       Impact factor: 16.806

9.  Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators.

Authors:  Jennifer B Kwon; Ashish Vankara; Adarsh R Ettyreddy; Joel D Bohning; Charles A Gersbach
Journal:  Stem Cell Reports       Date:  2020-04-23       Impact factor: 7.765

Review 10.  Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection.

Authors:  Marco P Alves; Nathalie J Vielle; Volker Thiel; Stephanie Pfaender
Journal:  Viruses       Date:  2018-10-30       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.